DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2007

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End

31/12/2007
Quarter2
Quarterly report for the financial period ended30/06/2007
The figureshave not been audited

Attachments

CCMD Q2.BOD.xls
92 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2007

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2007
30/06/2006
30/06/2007
30/06/2006
RM'000
RM'000
RM'000
RM'000
1Revenue
27,699
27,493
55,804
54,907
2Profit/(loss) before tax
10,468
10,456
21,334
20,917
3Profit/(loss) for the period
7,559
7,747
15,492
15,371
4Profit/(loss) attributable to ordinary equity holders of the parent
7,559
7,747
15,492
15,371
5Basic earnings/(loss) per share (sen)
5.45
5.56
11.16
11.03
6Proposed/Declared dividend per share (sen)
0.00
0.00
0.00
0.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
1.0500
1.0400

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameCCM DUOPHARMA BIOTECH BERHAD  
Stock Name CCMDBIO    
Date Announced23 Aug 2007  
CategoryFinancial Results
Reference NoCD-070823-42878